• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 与 S100B(ββ)结合的潜在构象异质性。

Potential conformational heterogeneity of p53 bound to S100B(ββ).

机构信息

Department of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66506, USA.

出版信息

J Mol Biol. 2013 Mar 25;425(6):999-1010. doi: 10.1016/j.jmb.2013.01.001. Epub 2013 Jan 8.

DOI:10.1016/j.jmb.2013.01.001
PMID:23313430
Abstract

The negative regulatory domain (NRD) of the p53 tumor suppressor is intrinsically disordered. It contains several posttranslational modification (PTM) sites that are important for regulation of p53 activity. Calcium-dependent binding of dimeric S100B(ββ) to p53-NRD blocks access to these PTM sites and disrupts the p53 tetramer to inhibit p53 activation. Previous nuclear magnetic resonance (NMR) structural studies have suggested that p53-NRD folds into a stable helix upon binding to S100B(ββ). Intriguingly, despite the well-converged and stably folded nature of the NMR structure ensemble, experimentally resolved intermolecular nuclear Overhauser enhancements (NOEs) are extremely weak; most have 5- to 6-Å upper bounds, and mainly involve the C-terminal segment of p53-NRD. Such a systematic lack of strong intermolecular NOEs could suggest that the p53/S100B(ββ) interface is more dynamic than currently believed. Indeed, extensive atomistic simulations in explicit solvent (with 1.0μs total effective sampling) revealed large heterogeneity in the S100B(ββ)-bound conformation of p53-NRD. Helix unwinding at the C-terminus allows key hydrophobic residues (Leu383 and Phe385) to make more extensive intermolecular contacts, whereas the highly helical N-terminus displays substantial flexibility in packing with S100B(ββ). Importantly, the predicted heterogeneous ensemble as a whole is highly consistent with experimental intermolecular NOEs, although many conformational sub-states coexist and individual sub-states satisfy only subsets of the NOE restraints. Furthermore, the simulated ensemble provides similar shielding of key PTM sites to support p53 inhibition. This study not only provides new insights into the structural basis of the p53/S100B(ββ) recognition but also highlights the importance of recognizing dynamic complexes in structural studies of intrinsically disordered protein interactions.

摘要

p53 肿瘤抑制因子的负调节域(NRD)本质上是无规则的。它包含几个翻译后修饰(PTM)位点,这些位点对于调节 p53 活性很重要。二聚体 S100B(ββ)与 p53-NRD 的钙依赖性结合阻止了这些 PTM 位点的接近,并破坏了 p53 四聚体,从而抑制了 p53 的激活。先前的核磁共振(NMR)结构研究表明,p53-NRD 在与 S100B(ββ)结合后折叠成一个稳定的螺旋。有趣的是,尽管 NMR 结构集合收敛良好且折叠稳定,但实验解析的分子间核奥弗豪瑟增强(NOE)非常弱;大多数有 5-6Å 的上限,主要涉及 p53-NRD 的 C 末端片段。这种系统缺乏强的分子间 NOE 可能表明 p53/S100B(ββ)界面比目前认为的更具动态性。事实上,在明确溶剂(总有效采样 1.0μs)中进行的广泛原子模拟揭示了 p53-NRD 与 S100B(ββ)结合构象的巨大异质性。C 末端的螺旋展开允许关键的疏水性残基(Leu383 和 Phe385)进行更广泛的分子间接触,而高度螺旋化的 N 末端在与 S100B(ββ)包装时表现出很大的灵活性。重要的是,预测的异构集合作为一个整体与实验分子间 NOE 高度一致,尽管许多构象亚态共存,并且单个亚态仅满足 NOE 约束的子集。此外,模拟集合还为关键 PTM 位点提供了类似的屏蔽,以支持 p53 抑制。这项研究不仅为 p53/S100B(ββ)识别的结构基础提供了新的见解,而且还强调了在结构研究中识别无序蛋白质相互作用的动态复合物的重要性。

相似文献

1
Potential conformational heterogeneity of p53 bound to S100B(ββ).p53 与 S100B(ββ)结合的潜在构象异质性。
J Mol Biol. 2013 Mar 25;425(6):999-1010. doi: 10.1016/j.jmb.2013.01.001. Epub 2013 Jan 8.
2
Structure of the negative regulatory domain of p53 bound to S100B(betabeta).与S100B(ββ)结合的p53负调控结构域的结构
Nat Struct Biol. 2000 Jul;7(7):570-4. doi: 10.1038/76797.
3
Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.与源自p53 C端调控结构域的肽段结合后,钙离子结合型大鼠S100B(ββ)C端的结构变化
Protein Sci. 1999 Sep;8(9):1743-51. doi: 10.1110/ps.8.9.1743.
4
Intrinsically disordered p53 extreme C-terminus binds to S100B(betabeta) through "fly-casting".内在无序的p53极端C末端通过“抛锚式”与S100B(ββ)结合。
J Am Chem Soc. 2009 Feb 18;131(6):2088-9. doi: 10.1021/ja809547p.
5
Fragmenting the S100B-p53 interaction: combined virtual/biophysical screening approaches to identify ligands.打断 S100B-p53 相互作用:结合虚拟/生物物理筛选方法来识别配体。
ChemMedChem. 2010 Mar 1;5(3):428-35. doi: 10.1002/cmdc.200900393.
6
Computational screening and design of S100B ligand to block S100B-p53 interaction.用于阻断S100B-p53相互作用的S100B配体的计算筛选与设计。
J Mol Graph Model. 2009 Jun-Jul;27(8):969-77. doi: 10.1016/j.jmgm.2009.02.006. Epub 2009 Feb 20.
7
Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography.小分子与钙结合的S100B靶蛋白结合裂隙中的独特位点结合,这是通过核磁共振和X射线晶体学表征的。
Biochemistry. 2009 Jul 7;48(26):6202-12. doi: 10.1021/bi9005754.
8
Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.钙依赖性S100B-p53肿瘤抑制因子相互作用的小分子抑制剂的鉴定与表征
J Med Chem. 2004 Oct 7;47(21):5085-93. doi: 10.1021/jm0497038.
9
Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.在存在和不存在源自p53 C末端负调控域的肽的情况下,S100B野生型和EF手型突变体的钙结合特性。
Biochemistry. 2005 May 17;44(19):7305-14. doi: 10.1021/bi050321t.
10
S100B(betabeta) inhibits the protein kinase C-dependent phosphorylation of a peptide derived from p53 in a Ca2+-dependent manner.S100B(ββ)以钙依赖的方式抑制源自p53的肽段的蛋白激酶C依赖性磷酸化。
Protein Sci. 1998 Mar;7(3):794-8. doi: 10.1002/pro.5560070330.

引用本文的文献

1
Machine Learning Generation of Dynamic Protein Conformational Ensembles.机器学习生成动态蛋白质构象集合。
Molecules. 2023 May 12;28(10):4047. doi: 10.3390/molecules28104047.
2
Toward Accurate Coarse-Grained Simulations of Disordered Proteins and Their Dynamic Interactions.实现无序蛋白质及其动态相互作用的精确粗粒化模拟。
J Chem Inf Model. 2022 Sep 26;62(18):4523-4536. doi: 10.1021/acs.jcim.2c00974. Epub 2022 Sep 9.
3
Advanced Sampling Methods for Multiscale Simulation of Disordered Proteins and Dynamic Interactions.用于无序蛋白质和动态相互作用的多尺度模拟的高级采样方法。
Biomolecules. 2021 Sep 28;11(10):1416. doi: 10.3390/biom11101416.
4
Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain.癌症相关突变扰乱了无序整体及 p53 转录激活域的无序内相互作用。
J Mol Biol. 2021 Jul 23;433(15):167048. doi: 10.1016/j.jmb.2021.167048. Epub 2021 May 11.
5
Bioinformatic Analysis and Biophysical Characterization Reveal Structural Disorder in G0S2 Protein.生物信息学分析和生物物理表征揭示了G0S2蛋白的结构无序性。
ACS Omega. 2020 Oct 5;5(40):25841-25847. doi: 10.1021/acsomega.0c03171. eCollection 2020 Oct 13.
6
Targeting Intrinsically Disordered Proteins through Dynamic Interactions.通过动态相互作用靶向内在无序蛋白质。
Biomolecules. 2020 May 11;10(5):743. doi: 10.3390/biom10050743.
7
Roles of computational modelling in understanding p53 structure, biology, and its therapeutic targeting.计算建模在理解 p53 结构、生物学及其治疗靶点中的作用。
J Mol Cell Biol. 2019 Apr 1;11(4):306-316. doi: 10.1093/jmcb/mjz009.
8
Intrinsic Disorder and Posttranslational Modifications: The Darker Side of the Biological Dark Matter.内在无序与翻译后修饰:生物暗物质的阴暗面
Front Genet. 2018 May 4;9:158. doi: 10.3389/fgene.2018.00158. eCollection 2018.
9
Enhanced Sampling of Intrinsic Structural Heterogeneity of the BH3-Only Protein Binding Interface of Bcl-xL.增强对 Bcl-xL BH3 仅蛋白结合界面固有结构异质性的采样。
J Phys Chem B. 2017 Oct 5;121(39):9160-9168. doi: 10.1021/acs.jpcb.7b06768. Epub 2017 Sep 27.
10
Digested disorder: Quarterly intrinsic disorder digest (January/February/March, 2013).消化紊乱:季度内在紊乱摘要(2013年1月/2月/3月)
Intrinsically Disord Proteins. 2013 Apr 1;1(1):e25496. doi: 10.4161/idp.25496. eCollection 2013 Jan-Dec.